The inhibitory effect of ketotifen on entrance of Toxoplasma gondii tachyzoites into macrophages of mouse

Journal of Mazandaran University of Medical Sciences

Volumn 23, Issue 110, 2014, Pages 74-80

  Daryani, Ahmad ^a   Ebrahimzadeh, Mohammad Ali ^b   Sharif, Mehdi ^a   Rezaei, Fatemeh ^a   Ahmadpour, Ehsan ^a   Sarvi, Shahab ^a   Ajami, Abolghasem ^c   Ziaei, Hajar ^a   Khalilian, Alireza ^c  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Entrance inhibition; Ketotifen; Mouse; Nucleated cells; Toxoplasma gondii

Indexed keywords

KETOTIFEN;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; INCUBATION TIME; MACROPHAGE; MOUSE; NONHUMAN; TACHYZOITE; TOXOPLASMA GONDII;

EID: 84907969158     PISSN: 17359279     EISSN: 17359260     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Weiss LM, Kim K. Toxoplasma Gondii: The Model Apicomplexan. Perspectives and Methods. New York, NY: Academic Press; 2011.
2. Mostafavi SN, Jalali Monfared L. Toxoplasmosis epidemiology in Iran: a systematic review. J Isfahan Med Sch 2012; 30(176): 1-15.
3. Dubey JP. Toxoplasmosis of Animals and Humans. 2nd ed. Boca Raton, FL: CRC Press; 2010.
4. Weiss LM, Kim K. Toxoplasma Gondii: The Model Apicomplexan: Perspectives and Methods. Philadelphia, PA: Elsevier/Academic Press; 2007.
5. Daryani A. Toxoplasma. Ardabil, Iran: Yavarian Publication; 2004. (Persian).
6. Nam HW, Kim DJ, Park SK, Choi WY. Inhibition of entry of Toxoplasma gondii into MDCK cells by fetal bovine serum. Korean J Parasitol 1993; 31(4): 379-82.
7. Ryning FW, Remington JS. Effect of cytochalasin D on Toxoplasma gondii cell entry. Infect Immun 1978; 20(3): 739-43.
8. Stokkermans TJ, Schwartzman JD, Keenan K, Morrissette NS, Tilney LG, Roos DS. Inhibition of Toxoplasma gondii replication by dinitroaniline herbicides. Exp Parasitol 1996; 84(3): 355-70.
9. D'Angelo JG, Bordon C, Posner GH, Yolken R, Jones-Brando L. Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle. J Antimicrob Chemother 2009; 63(1): 146-50.
10. Sweetman SC. Martindale: The Complete Drug Reference. 35th ed. London, UK: Pharmaceutical Press, 2007.
11. Goodman LS, Hardman JG, Limbird LE, Goodman Gilman A. Goodman & Gilmans The pharmacological basis of therapeutics. 9th ed. New York, NY: McGraw-Hill, Medical Publishing Division; 1996.
12. Cortez E, Stumbo AC, Saldanha-Gama R, Villela CG, Barja-Fidalgo C, Rodrigues CA, et al. Immunolocalization of an osteopontin-like protein in dense granules of Toxoplasma gondii tachyzoites and its association with the parasitophorous vacuole. Micron 2008; 39(1): 25-31.
13. Bajohr LL, Ma L, Platte C, Liesenfeld O, Tietze LF, Gross U, et al. In vitro and in vivo activities of 1-hydroxy-2-alkyl-4(1H) quinolone derivatives against Toxoplasma gondii. Antimicrob Agents Chemother 2010; 54(1): 517-21.